Presentation
A review of the new ISO Standard on Data De-identification: ISO/IEC 27559
Blog
RWE Meaning | Update: What the Omnibus FDA Amendments Mean for RWE
On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023, a ...
Blog
Replica Analytics Top 10 Round-up for 2022
By Replica staff
Presentation
Evaluating Privacy Risks in Synthetic Data Using Membership Disclosure
Publication
Synthetic data as an enabler for machine learning applications in medicine
Blog
Validating a Membership Disclosure Metric for Synthetic Health Data
By Lucy Mosquera | Posted On: October 11, 2022 We have just had a paper published in ...
Publication
Validating A Membership Disclosure Metric For Synthetic Health Data
Presentation
On the Validity of Statistical Analyses with Privacy-Preserving Synthetic Data
Presentation
Synthetic Data: The Future of Data Sharing?
Blog
RWE guidance watch: EUnetHTA’s Direct and Indirect Comparisons guidance
The European Network for Health Technology Assessment (EUnetHTA) recently published two ...
Presentation
Exploring the concept of Identifiability in Canada’s proposed Consumer Privacy Protection Act (Bill C-27)
Khaled El Emam, SVP & GM, Replica Analytics; Adam Kardash, Partner, ...
Blog
Aetion’s best practices referenced in ENCePP’s updated Guide on Methodological Standards in Pharmacoepidemiology
On July 1, 2022, the European Network of Centres for Pharmacoepidemiology and ...
Blog
New estimator uses synthetic data generation for more reliable evaluation of re-identification risk in datasets
By Lucy Mosquera and Abhik Das
Presentation
Assessing Re-identification Risk Using Synthetic Data
Publication
Measuring re-identification risk using a synthetic estimator to enable data sharing
Presentation
Synthetic Data as a Privacy Enhancing Technology
Blog
Why work at a startup? Because everything you do matters
Several years ago, during a hiring interview for a software engineer position, the ...
Presentation
Generating Synthetic Longitudinal Data
Blog
ISPOR Goes Real-World
Regulators, HTAs, and pharma leaders discuss RWE trends with Aetion experts.
Presentation
Utility Assessments in Synthetic Data
Blog
RWE Guidance: NICE’s RWE Framework
This month, the UK’s National Institute for Health and Care Excellence (NICE) released ...
Publication
Utility Metrics for Evaluating Synthetic Health Data Generation Methods: Validation Study
Blog
Utility Metrics for Evaluating Synthetic Data Generation Methods
By Lucy Mosquera and Xi Fang Posted On: April 8, 2022 In order to work with synthetic ...
Presentation